Figure 1D shows the protein levels of ARHGAP30 in subgroups of patients with LUAD, stratified based on sample type, individual cancer stage, ethnicity, sex, age, weight, tumor grade, and tumor histology (assessed using UALCAN [14] and CPTAC [15]). Here, ARHGAP30 is linked to neoplasm.